{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:07:33Z","timestamp":1787663253433,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41401-018-0155-y","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T06:24:11Z","timestamp":1540535051000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors"],"prefix":"10.1038","volume":"40","author":[{"given":"Fang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-zhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"155_CR1","first-page":"80","volume":"2","author":"R Teschke","year":"2014","unstructured":"Teschke R. Traditional Chinese medicine induced liver injury. J Clin Transl Hepatol. 2014;2:80\u201394.","journal-title":"J Clin Transl Hepatol"},{"key":"155_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/apt.12798","volume":"40","author":"R Teschke","year":"2014","unstructured":"Teschke R, Wolff A, Frenze C, Schulze J. Review article: herbal hepatotoxicity\u2014an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40:32\u201350.","journal-title":"Aliment Pharmacol Ther"},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/ijms17050588","volume":"17","author":"C Frenzel","year":"2016","unstructured":"Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci. 2016;17:588.","journal-title":"Int J Mol Sci"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms17010014","volume":"17","author":"G Danan","year":"2016","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17:14.","journal-title":"Int J Mol Sci"},{"key":"155_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/medicines3030018","volume":"3","author":"R Teschke","year":"2016","unstructured":"Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18.","journal-title":"Medicines"},{"key":"155_CR6","volume-title":"Pyrrolizidine alkaloids health and safety guide; health and safety guide no. 26","author":"WHO. International Programme on Chemical Safety, International Programme on Chemical Safety.","year":"1989","unstructured":"WHO. International Programme on Chemical Safety, International Programme on Chemical Safety. Pyrrolizidine alkaloids health and safety guide; health and safety guide no. 26. Geneva: WHO; 1989."},{"key":"155_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ejim.2007.03.006","volume":"18","author":"MY Chen","year":"2007","unstructured":"Chen MY, Cai JT, Du Q. Hepatic veno-occlusive disease associated with the use of Gynura segetum. Eur J Intern Med. 2007;18:609\u201316.","journal-title":"Eur J Intern Med"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3748\/wjg.v13.i10.1628","volume":"13","author":"N Dai","year":"2007","unstructured":"Dai N, Yu YC, Ren TH, Wu JG, Jiang Y, Shen LG, et al. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol. 2007;13:1628\u201331.","journal-title":"World J Gastroenterol"},{"key":"155_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N, Li M, Gao H, Ji Y, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2011;54:666\u201373.","journal-title":"J Hepatol"},{"key":"155_CR10","first-page":"711","volume":"55","author":"LD Deleve","year":"2000","unstructured":"Deleve LD, Mccuskey RS, Wang XD, Hu LP, Mccuskey MK, Epstein RB, et al. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie. 2000;55:711\u201326.","journal-title":"Pharmazie"},{"key":"155_CR11","first-page":"95","volume":"8","author":"BL Stegelmeier","year":"1999","unstructured":"Stegelmeier BL, Edgar JA, Colegate SM, Gardner DR, Schoch TK. Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins. 1999;8:95\u2013116.","journal-title":"J Nat Toxins"},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cbi.2015.09.011","volume":"243","author":"MB Yang","year":"2016","unstructured":"Yang MB, Ruan JQ, Fu PP, Lin G. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity. Chem Biol Interact. 2016;243:119\u201326.","journal-title":"Chem Biol Interact"},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1751-2980.2011.00552.x","volume":"13","author":"H Gao","year":"2012","unstructured":"Gao H, Li N, Wang JY, Zhang SC, Lin G. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis. 2012;13:33\u20139.","journal-title":"J Dig Dis"},{"key":"155_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.taap.2017.08.007","volume":"333","author":"ZL Huang","year":"2017","unstructured":"Huang ZL, Chen M, Zhang J, Sheng Y, Ji LL. Integrative analysis of hepatic microRNA and mRNA to identify potential biological pathways associated with monocrotaline-induced liver injury in mice. Toxicol Appl Pharmacol. 2017;333:35\u201342.","journal-title":"Toxicol Appl Pharmacol"},{"key":"155_CR15","doi-asserted-by":"publisher","first-page":"A1003","DOI":"10.1016\/S0016-5085(00)86165-X","volume":"118","author":"LD DeLeve","year":"2000","unstructured":"DeLeve LD, Ito Y, Machen NW, McCuskey MK, Wang XD, McCuskey RS. Embolization by sinusoidal lining cells causes the congestion of hepatic veno occlusive disease. Gastroenterology. 2000;118:A1003.","journal-title":"Gastroenterology"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Kenne KW, McDonald GB. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19:1171\u201380.","journal-title":"Hepatology"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1525-1594.1996.tb00652.x","volume":"20","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Iwaki H, Satoh M, Ikeda T, Ichimiya S, Suzuki N, et al. Veno-occlusive disease of the liver following bone marrow transplantation: a clinical-pathological study of autopsy cases. Artif Organs. 1996;20:1145\u201350.","journal-title":"Artif Organs"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40261-014-0242-x","volume":"34","author":"GM Keating","year":"2014","unstructured":"Keating GM. Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation. Clin Drug Invest. 2014;34:895\u2013904.","journal-title":"Clin Drug Invest"},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2016.12.015","volume":"795","author":"J Zhang","year":"2017","unstructured":"Zhang J, Sheng Y, Shi L, Zheng Z, Chen M, Lu B, et al. Quercetin and baicalein suppress monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats. Eur J Pharmacol. 2017;795:160\u20138.","journal-title":"Eur J Pharmacol"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.etap.2016.07.002","volume":"46","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, Shi L, Sheng Y, Zhang J, Lu B, Ji LL. Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: the potential contribution of NF\u03baB, Egr1, Nrf2, MAPKs and PI3K signals. Environ Toxicol Pharmacol. 2016;46:80\u20139.","journal-title":"Environ Toxicol Pharmacol"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1440-1746.2011.06661.x","volume":"26","author":"Z Chen","year":"2011","unstructured":"Chen Z, Huo JR, Yang L, Zhu HY. Effect of ligustrazine on mouse model of hepatic veno-occlusive disease induced by Gynura segetum. J Gastro Hepatol. 2011;26:1016\u201321.","journal-title":"J Gastro Hepatol"},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1872-034X.2011.00830.x","volume":"41","author":"HY Zhu","year":"2011","unstructured":"Zhu HY, Chu Y, Huo JR, Chen Z, Yang L. Effect of prednisone on transforming growth factor-\u03b21, connective tissue growth factor, nuclear factor-\u03baBp65 and tumor necrosis factor-\u03b2 expression in a murine model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum. Hepatol Res. 2011;41:795\u2013803.","journal-title":"Hepatol Res"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/jssc.201400314","volume":"37","author":"LX Fang","year":"2014","unstructured":"Fang LX, Xiong AZ, Yang X, Cheng WZ, Yang L, Wang ZT. Mass-spectrometry-directed analysis and purification of pyrrolizidine alkaloid Cis\/trans isomers in Gynura japonica. J Sep Sci. 2014;37:2032\u20138.","journal-title":"J Sep Sci"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1007\/s00204-017-2013-y","volume":"91","author":"M Yang","year":"2017","unstructured":"Yang M, Ruan J, Gao H, Li N, Ma J, Xue J, et al. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Arch Toxicol. 2017;91:3913\u201325.","journal-title":"Arch Toxicol"},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","volume":"23","author":"A Helmy","year":"2006","unstructured":"Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther. 2006;23:11\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"155_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","volume":"10","author":"M Wadleigh","year":"2003","unstructured":"Wadleigh M, Ho V, Momtaz P, Richardson P. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Fematol. 2003;10:451\u201362.","journal-title":"Curr Opin Fematol"},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","volume":"57j","author":"K Nakamura","year":"2012","unstructured":"Nakamura K, Hatano E, Narita M, Hayashino AM, Koyama Y, Nagata Y, et al. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9. J Hepatol. 2012;57j:1037\u201343.","journal-title":"J Hepatol"},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1631\/jzus.B1200112","volume":"14","author":"XZ Yu","year":"2013","unstructured":"Yu XZ, Ji T, Bai XJ, Liang L, Wang LY, Chen W, et al. Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum. J Zhejiang Univ\u2013Sci B (Biomed & Biotechnol). 2013;14:68\u201375.","journal-title":"J Zhejiang Univ\u2013Sci B (Biomed & Biotechnol)"},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12161-011-9271-8","volume":"5","author":"AMndashM Miguel","year":"2012","unstructured":"Miguel AM\u2013M, Mar\u00eda JT\u2013L, Aar\u00f3n FG\u2013C, Belinda V\u2013C. A capillary electrophoresis method for the determination of hydroxyproline as a collagen content index in meat products. Food Anal Methods. 2012;5:464\u201370.","journal-title":"Food Anal Methods"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11373-007-9216-9","volume":"15","author":"LM Wu","year":"2008","unstructured":"Wu LM, Wu XX, Sun Y, Kong XW, Zhang YH, Xu Q. A novel synthetic oleanolic acid derivative (CPU-II2) attenuates liver fibrosis in mice through regulating the function of hepatic stellate cells. J Biomed Sci. 2008;15:251\u20139.","journal-title":"J Biomed Sci"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","volume":"59","author":"SM Robinson","year":"2013","unstructured":"Robinson SM, Mann J, Vasilaki A, Mathers J, Burt AD, Oakley F, et al. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model. J Hepatol. 2013;59:318\u201326.","journal-title":"J Hepatol"},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00204-016-1713-z","volume":"91","author":"L Zhu","year":"2017","unstructured":"Zhu L, Xue J, Xia Q, Fu PP, Lin G. The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice. Arch Toxicol. 2017;91:949\u201365.","journal-title":"Arch Toxicol"},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.redox.2017.02.020","volume":"12","author":"X Yang","year":"2017","unstructured":"Yang X, Wang H, Ni HM, Xiong AZ, Wang ZT, Sesaki H, et al. Inhibition of Drp1 protects against senecionine-induced mitochondriamediated apoptosis in primary hepatocytes and in mice. Redox Biol. 2017;12:264\u201373.","journal-title":"Redox Biol"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00204-017-2114-7","volume":"92","author":"F Kolrep","year":"2018","unstructured":"Kolrep F, Numata J, Kneuer C, Preiss-Weigert A, Lahrssen-Wiederholt M, Schrenk D, et al. In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: microsomal degradation. Arch Toxicol. 2018;92:1089\u201397.","journal-title":"Arch Toxicol"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1021\/tx900328f","volume":"23","author":"YQ He","year":"2010","unstructured":"He YQ, Yang L, Liu HX, Zhang JW, Liu Y, Fong A, et al. Glucuronidation, a new metabolic pathway for pyrrolizidine alkaloids. Chem Res Toxicol. 2010;23:591\u20139.","journal-title":"Chem Res Toxicol"},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/hep.510290615","volume":"29","author":"LD DeLeve","year":"1999","unstructured":"DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology. 1999;29:1779\u201391.","journal-title":"Hepatology"},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.1840380416","volume":"38","author":"LD DeLeve","year":"2003","unstructured":"DeLeve LD, Wang X, Kanel GC, Ito Y, Bethea NW, McCuskey MK, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology. 2003;38:900\u20138.","journal-title":"Hepatology"},{"key":"155_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","volume":"125","author":"LD Deleve","year":"2003","unstructured":"Deleve LD, Wang X, Tsai J, Kanel G, Strasberg S, Tokes ZA. Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology. 2003;125:882\u201390.","journal-title":"Gastroenterology"},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/taap.1994.1167","volume":"127","author":"WG Chung","year":"1994","unstructured":"Chung WG, Buhler DR. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs. Toxicol Appl Pharmacol. 1994;127:314\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"key":"155_CR40","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1021\/tx0340302","volume":"16","author":"G Lin","year":"2003","unstructured":"Lin G, Cui YY, Liu XQ. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem Res Toxicol. 2003;16:768\u201374.","journal-title":"Chem Res Toxicol"},{"key":"155_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/10937409809524557","volume":"1","author":"AE Schultze","year":"1998","unstructured":"Schultze AE, Roth RA. Chronic pulmonary hypertension\u2014the monocrotaline model and involvement of the hemostatic system. J Toxicol Environ Health B Crit Rev. 1998;1:271\u2013346.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"155_CR42","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1097\/MD.0000000000000942","volume":"94","author":"XX Wang","year":"2015","unstructured":"Wang XX, Qi XS, Guo XZ. Tusanqi-related sinusoidal obstruction syndrome in China: a systematic review of the literatures. Medicine. 2015;94:e942.","journal-title":"Medicine"},{"key":"155_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","volume":"364","author":"S Tsukada","year":"2006","unstructured":"Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33\u201360.","journal-title":"Clin Chim Acta"},{"key":"155_CR44","first-page":"409","volume":"28","author":"MX Shao","year":"2013","unstructured":"Shao MX, Wang WT, Zhao ZY, Tang LD. A new drug treating idiopathic pulmonary fibrosis: pirfenidone. Drugs Clin. 2013;28:409\u201314.","journal-title":"Drugs Clin"},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bone.2011.11.022","volume":"50","author":"X Wan","year":"2012","unstructured":"Wan X, Li ZG, Ying JM. Effect of transforming growth factor beta (TGF-\u03b2) receptor I kinase inhibitor on prostate cancer bone growth. Bone. 2012;50:695\u2013703.","journal-title":"Bone"},{"key":"155_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejca.2007.10.008","volume":"44","author":"L Bueno","year":"2008","unstructured":"Bueno L, Alwis DP, Pitou C. Semi-mechanistic modeling of the tumor growth inhibitory effects of LY2157299, a new type I receptor TGF-\u03b2 kinase antagonist, in mice. Eur J Cancer. 2008;44:142\u201350.","journal-title":"Eur J Cancer"},{"key":"155_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejphar.2014.07.026","volume":"740","author":"LA Ahmed","year":"2014","unstructured":"Ahmed LA, Obaid AA, Zaki HF, Agha AM. Role of oxidative stress, inflammation, nitric oxide and transforming growth factor-beta in the protective effect of diosgenin in monocrotaline-induced pulmonary hypertension in rats. Eur J Pharmacol. 2014;740:379\u201387.","journal-title":"Eur J Pharmacol"},{"key":"155_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.mbs.2011.03.005","volume":"231","author":"BN Brown","year":"2011","unstructured":"Brown BN, Price IM, Toapanta FR. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math Biosci. 2011;231:186\u201396.","journal-title":"Math Biosci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0155-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:24Z","timestamp":1684616484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0155-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0155-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}